The FDA announces a recall of Zantac (ranitidine hydrochloride)
Zantac is a very popular antacid medication that has been on the market since the early 1980s. People commonly use Zantac for acid reflux, heartburn, and a host of other stomach, throat, and gastrointestinal issues. At no fault of their own, millions of Americans have unknowingly exposed themselves to a risk for cancer by taking Zantac.
Since the 1980s, numerous studies have demonstrated a link between the NDMA in Zantac and cancer. Mounting evidence also allegedly shows that Sanofi and Boehringer Ingelheim, the big pharma companies that make Zantac (ranitidine hydrochloride), concealed the Zantac cancer link from millions of people who took the drug for heartburn, gastric and duodenal ulcers, gastroesophageal reflux disease (GERD), sour stomach, Barrett’s esophagus, acid reflux, and other issues. For almost three decades, Americans have relied on Zantac, often at the recommendation of their doctor. This deception came as the companies made unprecedented profits from Zantac, the first drug to generate $1 billion in sales.
The U.S. Food and Drug Administration (FDA) announced on September 13, 2019 that it is investigating Zantac cancer risks after testing of Zantac 150 tablets found the commonly-used heartburn medication contains NDMA at levels up to 3,000 times greater than the FDA’s daily intake limit.
NDMA is used in aviation and rocket fuel and industrial lubricants. It is also a by-product of several industrial processes, including gasoline refining and the treatment of wastewater containing nitrogen. Under the federal Emergency Planning and Community Right-to-Know Act of 1986 (EPCRA), NDMA is classified as “extremely hazardous.”
IMPORTANT ZANTAC UPDATE: The U.S. Food and Drug Administration announced on April 1, 2020 that it is requesting manufacturers to withdraw all Zantac and generic Zantac OTC ranitidine drugs from the market effective immediately. The FDA determined that N-Nitrosodimethylamine (NDMA) in some ranitidine medications “increases over time and when stored at higher than room temperatures and may result in consumer exposure to unacceptable levels…” The FDA, the Environmental Protection Agency (EPA), and the World Health Organization (WHO) all classify NDMA as a cancer-causing substance.
With countless people now stricken with cancer after taking Zantac, many are turning to the courts and filing a Zantac lawsuit to hold Sanofi and Boehringer Ingelheim accountable for their reckless disregard for human health and willingness to put profit over people.
The network of attorneys at Consumer Coalition have vast experience holding big corporations accountable for concealing the true dangers of consumer products. Consumer Coalition intends to hold the drug makers accountable for allegedly concealing the Zantac cancer link and putting profit before people. Across all areas of practice, they have successfully obtained billions of dollars in verdicts and settlements on behalf of our attorneys' clients.
If you or a member of your family was diagnosed with cancer after taking Zantac, you may be eligible to file a Zantac lawsuit against Sanofi and you may be eligible for compensation for the pain, suffering, medical expenses and other losses associated with Zantac cancer. More important for some is the opportunity to hold Sanofi accountable for negligence by filing a Zantac cancer lawsuit. On the contrary, if you took Zantac but never developed cancer, you could still seek compensation by filling a class action lawsuit against the manufacturers of Zantac. A Zantac class action lawsuit would allow consumers who purchased prescription or generic Zantac to regain the money spent on purchasing the medication.
What Do You Need To Do To Claim It?
Step 1: Click the red button below.
Step 2: On the next page, answer a few questions about your personal situation (takes 30 seconds).